Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Psoriatic Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00646178
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy

Who this might be right for
ArthritisPsoriatic
Abbott 102
Large-scale testing (Phase 3)Study completedNCT03370133
What this trial is testing

Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis
UCB Biopharma SRL 567
Early research (Phase 1)Ended earlyNCT00787137
What this trial is testing

Single Dose PG102 in Patients With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
PanGenetics UK Limited 17
Testing effectiveness (Phase 2)Study completedNCT05071664
What this trial is testing

Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 91
Post-approval studies (Phase 4)Looking for participantsNCT07160231
What this trial is testing

REDO-JAK: Dose Reduction of Janus Kinase Inhibitors in Patients With Inflammatory Rheumatic Diseases

Who this might be right for
Rheumatoid Arthritis (RA)Psoriatic Arthritis (PsA)Axial Spondyloarthritis (AxSpA)
Sint Maartenskliniek 200
Large-scale testing (Phase 3)Study completedNCT01392326
What this trial is testing

Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 606
Large-scale testing (Phase 3)Study completedNCT00235885
What this trial is testing

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Abbott 445
Large-scale testing (Phase 3)Active Not RecruitingNCT04882098
What this trial is testing

Guselkumab in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 1,054
Large-scale testing (Phase 3)Study completedNCT02404350
What this trial is testing

Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Novartis Pharmaceuticals 997
Large-scale testing (Phase 3)Study completedNCT03148860
What this trial is testing

Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA

Who this might be right for
Psoriatic Arthritis
Dr. Frank Behrens 186
Testing effectiveness (Phase 2)Looking for participantsNCT07321873
What this trial is testing

Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 240
Testing effectiveness (Phase 2)Study completedNCT05153148
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Takeda 305
Large-scale testing (Phase 3)Ended earlyNCT04115748
What this trial is testing

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy

Who this might be right for
Psoriatic Arthritis
Gilead Sciences 67
Not applicableStudy completedNCT04541810
What this trial is testing

Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Atopic Dermatitis (AD)Ankylosing Spondylitis (AS)+1 more
AbbVie 2,369
Large-scale testing (Phase 3)Study completedNCT05083182
What this trial is testing

Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 48
Large-scale testing (Phase 3)Looking for participantsNCT07286058
What this trial is testing

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Takeda 1,182
Large-scale testing (Phase 3)Study completedNCT03158285
What this trial is testing

A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 741
Large-scale testing (Phase 3)Looking for participantsNCT06100744
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Who this might be right for
Juvenile Psoriatic Arthritis
AbbVie 40
Large-scale testing (Phase 3)Looking for participantsNCT07295509
What this trial is testing

Picankibart in Patients With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 222
Not applicableActive Not RecruitingNCT06905028
What this trial is testing

Exploratory Clinical Study on Fasting in Psoriasis and Psoriatic Arthritis (RiseFast)

Who this might be right for
Psoriasis ArthritisPsoriasis (PsO)
Charite University, Berlin, Germany 30
Next Page